The scientific opportunities identified in the 2011 NICHD Vision Workshop on Reproduction included the need for innovative and safer methods of contraception. Combined hormonal contraceptive methods have been used for more than 50 years and are very effective if used as directed, but failures occur due to incorrect use. Several factors may contribute to irregular use: (1) Concerns about ethinyl estradiol (EE), the synthetic estrogen in most formulations, which is associated with an increased risk of a venous thromboembolism (VTE) as well as nausea and headache. (2) The need for daily attention. Despite the availability of many contraceptive options, the need for innovative contraceptive methods allowing improved compliance is real. In addition, little is known on the effects of contraceptives on the brain, although recent literature showed a neuroprotective, neuroregenerative and promyelinating effect of some, but not all molecules used for contraception in young women. Nestorone? (NES), a nonandrogenic progestin currently developed for contraception has also been shovm to have potential beneficial outcomes in inducing and sustaining the regenerative capacity of the brain and also in stimulating the myelin repair in animal models. We propose to develop a novel, user-controlled semi long-acting contraceptive method to address the safety issues surrounding the use of EE as well as the compliance problems related to the need for frequent user attention. This method consists of a vaginal ring delivering 17beta-estradiol (E2), a natural estrogen not associated with increased VTE risk, plus NES, a progestin with potential benefits. The vaginal ring is designed to be used continuously for 3 months. In parallel with an initial clinical study of the NES/E2 vaginal ring, research will be conducted on regenerative capacity of the brain and promyelinating effects of NES + E2 in cell systems and validated animal models at contraceptive doses. This multidisciplinary proposal is consistent with goals identified in the 2011 NICHD Scientific Vision Workshops on Reproduction and Plasticity. Should the results continue to be positive, further research would include clinical evaluation of the NES/E2 ring as a potential safer contraceptive with additional activity (promyelinating effects) for women with multiple sclerosis and/or with a positive effect on the cognitive function.

Public Health Relevance

A novel user-controlled contraceptive vaginal ring (CVR) with potential improvements in safety and ease of use will be developed. Each 3-month ring will deliver natural estradiol (E2), having less of the side effects associated with synthetic estrogens, and a non-androgenic progestin (Nestorone?, NES). Potential benefits of E2 and NES on the brain will be tested in animals and may lead to clinical benefits on cognitive function and mvtilin repair.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HD029990-22
Application #
8549279
Study Section
Special Emphasis Panel (ZHD1-DRG-H)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
22
Fiscal Year
2013
Total Cost
$214,684
Indirect Cost
Name
Population Council
Department
Type
DUNS #
071050090
City
New York
State
NY
Country
United States
Zip Code
10017
Chen, Haiqi; Mruk, Dolores D; Xia, Weiliang et al. (2016) Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) - Lesson from Adjudin. Curr Med Chem 23:701-13
Tang, Elizabeth I; Mruk, Dolores D; Cheng, C Yan (2016) Regulation of microtubule (MT)-based cytoskeleton in the seminiferous epithelium during spermatogenesis. Semin Cell Dev Biol 59:35-45
Venkatesh, Deepak; Mruk, Dolores; Herter, Jan M et al. (2016) AKAP9, a Regulator of Microtubule Dynamics, Contributes to Blood-Testis Barrier Function. Am J Pathol 186:270-84
Li, Nan; Mruk, Dolores D; Lee, Will M et al. (2016) Is toxicant-induced Sertoli cell injury in vitro a useful model to study molecular mechanisms in spermatogenesis? Semin Cell Dev Biol 59:141-156
Gao, Ying; Lui, Wing-Yee; Lee, Will M et al. (2016) Polarity protein Crumbs homolog-3 (CRB3) regulates ectoplasmic specialization dynamics through its action on F-actin organization in Sertoli cells. Sci Rep 6:28589
Li, Nan; Mruk, Dolores D; Chen, Haiqi et al. (2016) Rescue of perfluorooctanesulfonate (PFOS)-mediated Sertoli cell injury by overexpression of gap junction protein connexin 43. Sci Rep 6:29667
Chen, Haiqi; Mruk, Dolores D; Lee, Will M et al. (2016) Planar Cell Polarity (PCP) Protein Vangl2 Regulates Ectoplasmic Specialization Dynamics via Its Effects on Actin Microfilaments in the Testes of Male Rats. Endocrinology 157:2140-59
Tang, Elizabeth I; Lee, Will M; Cheng, C Yan (2016) Coordination of Actin- and Microtubule-Based Cytoskeletons Supports Transport of Spermatids and Residual Bodies/Phagosomes During Spermatogenesis in the Rat Testis. Endocrinology 157:1644-59
Wen, Qing; Cheng, C Yan; Liu, Yi-Xun (2016) Development, function and fate of fetal Leydig cells. Semin Cell Dev Biol 59:89-98
Jesus, Tito T; Oliveira, Pedro F; Silva, Joaquina et al. (2016) Mammalian target of rapamycin controls glucose consumption and redox balance in human Sertoli cells. Fertil Steril 105:825-833.e3

Showing the most recent 10 out of 225 publications